Next Article in Journal
ESI(+)-MS and GC-MS Study of the Hydrolysis of N-Azobenzyl Derivatives of Chitosan
Next Article in Special Issue
Resveratrol: Anti-Obesity Mechanisms of Action
Previous Article in Journal
Poly(Ethylene Glycol)-Based Backbones with High Peptide Loading Capacities
Previous Article in Special Issue
Enhancing the Delivery of Resveratrol in Humans: If Low Bioavailability is the Problem, What is the Solution?
Article Menu

Export Article

Open AccessArticle
Molecules 2014, 19(11), 17578-17603; doi:10.3390/molecules191117578

The Sustained Delivery of Resveratrol or a Defined Grape Powder Inhibits New Blood Vessel Formation in a Mouse Model of Choroidal Neovascularization

1
Ophthalmic Research Center, Shahid Beheshti University of Medical Sciences, Tehran 1666663111, Iran
2
Department of Ophthalmology and Visual Sciences, University of Wisconsin, Madison, WI 53792 USA
3
Wills Eye Hospital, Philadelphia, PA 19107, USA
4
Department of Nutrition, Dietetics and Food Science, Brigham Young University, Provo, UT 84602, USA
*
Author to whom correspondence should be addressed.
Received: 26 August 2014 / Revised: 20 October 2014 / Accepted: 22 October 2014 / Published: 30 October 2014
(This article belongs to the Special Issue Resveratrol)
View Full-Text   |   Download PDF [3975 KB, uploaded 30 October 2014]   |  

Abstract

The objective of this study was to determine whether resveratrol or a defined, reconstituted grape powder can attenuate the formation of new blood vessels in a mouse model of choroidal neovascularization (CNV). To accomplish this objective, C57BL/6J mice were randomized into control or treatment groups which received either resveratrol or grape powder by daily oral gavage, resveratrol or grape powder delivered ad libitum through the drinking water, or resveratrol by slow release via implanted osmotic pumps. A laser was used to rupture Bruch’s membrane to induce CNV which was then detected in sclerochoroidal eyecups stained with antibodies against intercellular adhesion molecule-2. CNV area was measured using fluorescence microscopy and Image J software. Ad libitum delivery of both resveratrol and grape powder was shown to significantly reduce the extent of CNV by 68% and 57%, respectively. Parallel experiments conducted in vitro demonstrated that resveratrol activates p53 and inactivates Akt/protein kinase B in choroidal endothelial cells, contributing to its anti-proliferative and anti-migratory properties. In addition resveratrol was shown to inhibit the formation of endothelial cell networks, augmenting its overall anti-angiogenic effects. The non-toxic nature of resveratrol makes it an especially attractive candidate for the prevention and/or treatment of CNV. View Full-Text
Keywords: age-related macular degeneration; choroidal neovascularization; angiogenesis; natural products; resveratrol; grape constituents age-related macular degeneration; choroidal neovascularization; angiogenesis; natural products; resveratrol; grape constituents
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Kanavi, M.R.; Darjatmoko, S.; Wang, S.; Azari, A.A.; Farnoodian, M.; Kenealey, J.D.; van Ginkel, P.R.; Albert, D.M.; Sheibani, N.; Polans, A.S. The Sustained Delivery of Resveratrol or a Defined Grape Powder Inhibits New Blood Vessel Formation in a Mouse Model of Choroidal Neovascularization. Molecules 2014, 19, 17578-17603.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]

Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top